A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting...

In a follow-up on the hepatitis A outbreak reported in southeastern Michigan, the Michigan Department of Health and Human Services (MDHHS) continues to see an elevated number of hepatitis A cases in...

On Thursday, Dynavax Technologies Corporation announced that the U.S. Food and Drug Administration (FDA) approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection...

The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal...

The low efficacy of last year’s influenza vaccine can be attributed to a mutation in the H3N2 strain of the virus, a new study reports. Due to the mutation, most people receiving the egg-grown vaccine...

Takeda Pharmaceutical Company Limited today announced that data from an 18-month interim analysis of the ongoing Phase 2 DEN-204 trial of its live, attenuated tetravalent dengue vaccine candidate, TAK-003...

The Los Angeles County Department of Public Health (Public Health) is reminding men who have sex with men (MSM) to get the hepatitis A vaccine. Public Health reports 12 cases among MSM so far in 2017,...

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska...

The number of confirmed and probable mumps cases at Syracuse University (SU) continue to rise with the latest count at 29 and 64, respectively. The surge in the contagious viral disease prompted local...

Vaxart, Inc., a privately-held, clinical stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that its H1 influenza oral tablet...